Benefits to nonparticipants
Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- The morality of risks in research: reflections on Kumar
- Challenge studies of human volunteers: ethical issues
- Ethical guidelines for deliberately infecting volunteers with COVID-19
- How to keep high-risk studies ethical: classifying candidate solutions
- When should conscientious objection be accepted?
- Intuitions, principles and consequences
- Moral dimensions
- The unwitting sacrifice problem
- A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations
- Good parents would not fulfil their obligation to genetically enhance their unborn children